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Abstract
To determine the breadth and underpinning of changes in immunocyte gene expression due to
genetic variation in mice we performed, as part of the Immunological Genome Project, gene
expression profiling for CD4+ T cells and neutrophils purified from 39 inbred strains of the Mouse
Phenome Database. Considering both cell types, a large number of transcripts showed significant
variation across the inbred strains, 22% of the transcriptome varying by two-fold or more. These
included 119 loci with apparently complete loss-of-function, where the corresponding transcript
was not expressed in some of the strains, representing a useful resource of “natural knockouts”.
We identified 1,222 cis- expression quantitative trait loci (cis-eQTL) that control some of this
variation. Most (60%) cis-eQTLs were shared between T cells and neutrophils, but a significant
portion uniquely impacted one of the cell types, suggesting cell-type specific regulatory
mechanisms. Using a conditional regression algorithm we predicted regulatory interactions
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between transcription factors and potential targets, and demonstrated that these predictions overlap
with regulatory interactions inferred from transcriptional changes during immunocyte
differentiation. Finally, comparison of these and parallel data from CD4+ T cells of healthy
humans demonstrated intriguing similarities in variability of a gene's expression: the most variable
genes tended to be the same in both species, and there was an overlap in genes subject to strong
cis-acting genetic variants. We speculate that this “conservation of variation” reflects a differential
constraint on intra-species variation in expression levels of different genes, either through lower
pressure for some genes, or by favoring variability for others.
Introduction
For more than a century, inbred mice have played a unique role in biomedical research.
Their group homogeneity, phenotypic reproducibility, and genetic stability over time
haveled tokey discoveries in essentially every area of biomedical research (1), including the
discovery of fundamental concepts of immunology such as histocompatibility, MHC
restriction, or genetic susceptibility to autoimmune diseases. The near-homogeneous nature
of an inbred strain's genome underlies the extraordinary power of targeted germline
modifications, and has supported mapping of loci associated with disease or phenotypic
traits. The genomes of laboratory strains have been molded by strong selective pressures
linked to their domestication by mouse fanciers in China and Europe, then to inbreeding and
allele fixation in biomedical research colonies. These genomes incorporate segments from
several origins (2), as now clearly established by the decoding of the complete genome of
the reference C57BL/6J, followed by a number of other inbred strains (3,4). Efforts to
standardize and integrate phenotypic and genetic information, as exemplified by the Mouse
Phenome Database project (MPD) (5), are also helping to exploit the full potential of inbred
strains in biomedical research.
The Immunological Genome Project (ImmGen) is an international collaboration of
laboratories that collectively perform a thorough dissection of gene expression and its
regulation in the immune system of the mouse. Genome-wide gene expression data have
been collected for ∼250 immunological cell types of the mouse, yielding insights into
genomic correlates of immunocyte differentiation and lineages (6). The assembled data also
enabled predictions about regulatory networks that underlie mouse hematopoiesis (7). The
first phase of the ImmGen project mainly used the reference C57BL/6J strain, and thus
focused on identifying changes in gene expression during differentiation and activation in
the context of a unique genome. Yet there is much value in analyzing the impact of
functional genetic variation on gene expression levels. Variants influencing gene expression
are pervasive in mammalian species, and comprise a large majority of the disease-related
variants identified in genome wide association studies (GWAS)(8). Combined analysis of
gene expression and genotype data across a genetically diverse population is a powerful
means to understand the impact of genotypic variation on cellular processes, and ultimately
to build mechanistic models that link genetic variation to detailed cellular processes in a
context-specific manner (8,9). Several comparative analyses of gene expression have been
performed across inbred mouse strains(10-14), but were of limited breadth and/or performed
in celltypes not directly relevant to ImmGen.
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In terms of understanding human disease, while the mouse models have been invaluable in
establishing fundamental paradigms of immunologic function, caution has been suggested in
translating findings from the mouse to the human immune system (15). Similarities and
differences have been reported in the genomic underpinning of immune lineages of human
and mouse, whether at steady state or after cell activation (16-19). A direct comparison of
the genetic underpinning of these differences would also be valuable in ascertaining what
mouse models can be usefully applied to understand human diseases and their genetics.
To better understand the effect of genetic variation on the mouse immune system, we
generated RNA expression data for 39 of the main inbred strains in the MPD “Priority Strain
Panel”. Using rigorous ImmGen standard operating procedures, genome-wide expression
data were generated for two immunological cell types, CD4+ T cells (T4) and
polymorphonuclear neutrophils (granulocytes, GN). These were chosen to represent the
main lymphoid and myeloid branches of the immune system, and its adaptive and innate
facets. This effort paralleled a study of similar design in an ethnically diverse population of
healthy humans, the “ImmVar” study, where genotype and gene expression data were
collected for CD4+ T cell and CD14+CD16- monocytes [(20,21) and Ye et al, submitted].
This matching study design allowed us to compare transcriptional variability and its roots in
the two species. Here, we first report on the impact of genetic background on gene
expression levels in mouse T4and GN, identify cis expression quantitative trait loci (eQTL),
and chart regulatory interactions that can be inferred from the perturbation of the regulatory
network by genetic variation. Second, we compare the impact of functional variation in
human and mouse, by exploring the overlap between expression variability and its genetics
in the two species.
Materials and Methods
Gene expression and genotype data
Inbred mouse strains from the MDP Priority Strain Panel, representing 39 strains, were
obtained from the Jackson Laboratory production facility in Bar Harbor, Maine, at five
weeks of age. All mice were bred in the Jackson Laboratory production facility under SPF
conditions. CD3+CD4+CD62L+ naïve T splenocytes and CD11b+Ly6G+ bone marrow
granulocytes were sorted from pools of two to three mice. Two biological replicates were
generated for each strain using the ImmGen standard operating protocol (SOP;
www.immgen.org). Gene expression data was generated for bone marrow granulocytes
(GN) and CD4+ T splenocytes (T4) using Affymetrix ST1.0 microarrays, the platform used
for the main ImmGen compendium, resulting in the quantification of expression levels for
25,134 probes corresponding to 21,951 unique genes. Data were processed and normalized
using the ImmGen standard operating protocol (www.immgen.org). When indicated, data
were filtered to only include genes with >0.95 probability of expression (or a mean of >120
expression on the intensity scale; see SOP). This filtering criteria resulted in 11,598 and
11,285 expressed transcripts in T4, and GN, respectively, with 131,85 transcripts expressed
in one or the other, and 9,698 transcripts expressed in both cell types. A threshold for
absence of expression was also set at <0.05 probability of expression (or a <42 expression
level on intensity scale). Genotype data was obtained from the mouse HapMap genotype
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resource (http://mouse.cs.ucla.edu/mousehapmap) (22). Only genotyped SNPs with minor
allele frequency (MAF) greater than 0.05 and no more than 10% missing rate (resulting in a
total of 96,779 SNPs) were used in this study.
Defining the true variability (TV) metric, bimodality in gene expression, and complete loss
of function loci
All analyses were performed in the MATLAB computing environment (R2013a, v
8.1.0.604).
At least two biological replicates were available for each mouse and each cell type (for the
strains for which there were more than two replicates, we randomly chose two of the
replicates for this analysis). For the TV metric, two quantities were computed for each gene
and each cell type using the log transformed data: (1) the between-strains mean absolute
deviation, and then divided by the mean gene expression level for that gene; (2) the average
of within-strains mean absolute deviation, where mean absolute deviation (MAD) for each
strain was computed using the two replicates for that strain, and then divided by the mean
gene expression level for that gene. The TV score for each gene was defined as the
difference between the first quantity, representing both meaningful and unwanted
variability, and the second quantity, representing the unwanted variability. We note that
there are two main differences between the TV metric proposed here and a standard
ANOVA approach: first, we chose to quantify variability using MAD as opposed to
variance because the latter gives more weight to extreme values. Second, as opposed to an
associated F-statistic in ANOVA, where the test statistics (interpreted as the true variability
score) is the ratio of two variances, here we use the difference of the two MADs as the score.
We chose to use the difference so to emphasize the magnitude of the variability, in addition
to the relative variability of the within-strains and between-strains MAD.
Bimodal genes were identified using two criteria: (1) based on the assessment of the fit of a
mixture of Gaussian with two components to expression levels across the strains, and (2) a
threshold on the fold difference between high and low expressing strains. The mixture of
Gaussians were fit using MATLAB's gm distribution function (MATLAB R2013a, v
8.1.0.604). A likelihood ratio test was used to assign a bimodality p-value to each gene by
comparing the likelihood of mixture of Gaussian with two components with simply the fit of
a single Gaussian. Genes with bimodality p-value < 10-6 and at least a two-fold difference in
top two high expressing and bottom two low expressing strains were identified as bimodal.
Complete loss-of-function loci were identified as those bimodal genes that additionally
satisfied a strict threshold on expression levels: an expression of less than 42 (corresponding
to <0.05 probability of expression) for at least two strains and expression greater than 120
(corresponding to >0.95 probability of expression) for at least two strains.
Expression quantitative trait loci (eQTL) association mapping for mouse
It is well appreciated that genetic association studies in inbred strains are impacted by
population stratification, which violates the assumptions of standard statistical tests and lead
to an abundance of false positive associations (and therefore an inflation of association p-
values)(23). To account for population stratification, we used linear regression, regressing
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out the effect of the top two genotype PCs from log gene expression data. We chose two
PCs by quantifying the inflation of observed p-values using the λ statistic (24) as we varied
the number of removed genotype PCs from one to five. A cis window of 1Mb centered on
transcription start site (TSS) was used to identify all cis SNPs for each gene.
Joint analysis—To increase statistical power, for the joint analysis, residual expression
data (after removing genotype PCs, see above) from both cell types were concatenated,
resulting in a dataset with 2×39 samples and 13,185 expressed transcripts (expressed in at
least one cell type). For each SNP-gene pair, the Wilcoxon rank sum statistic (as
implemented in MATLAB R2013a, v 8.1.0.604) was used to test whether the expression of
the gene was significantly different between strains with the reference or the alternative
allele at the given SNP. 10,000 permutations were performed for each SNP-gene pair,
permuting the assignment of SNP values to strains while keeping intact the correspondence
between genotype assigned to the T4 and GN sample for the same strain (thus accounting
for “repeated” samples). A gene-level p-value was assigned that accounted for the number
of tested SNPs per gene by using the minimum permutation p-value across all tested SNPs
for that gene as the null distribution (25,26). Final set of cis-eQTLs were defined by setting
a 5% FDR threshold on the gene-level p-values.
Cell-specific eQTL analysis—Cell-specific eQTLs were identified by testing the
significance of an interaction term between genotype and cell-type indicator in a linear
regression setting, where the fit of the baseline model (no interaction) with one that
additionally included a cell-type-indicator by genotype interaction term was assessed using
an F-test. In particular, we model the expression level of gene gin tissue t for strain i as xg,t,i
= αg,t + βgsi + γg,tsi where αg,t is genotype-independent tissue-specific effect for tissue t and
gene g, βg is the tissue-shared genotype effect, and γg,t represents the cell-specific genotype
effect for tissue t. As above, gene-level p-values were computed using 10,000 permutations
(permuting the assignment of genotype values to the strains).
Constructing regulatory networks in mouse and validation using Ontogenet links
For constructing regulatory networks, genes expressed in both cell types and identified to
have non-negligible TV scores (as per Figure S1A) were used, which resulted in 3675
analyzed genes. Among these 164 are TFs, as defined in (7). Two networks (one for each
cell type) were constructed using stepwise regression, where a sparse set of TFs (regulators)
were identified for each target gene (set of targets includes both TFs and non-regulatory
genes). More specifically, for each target gene, stepwise regression was performed using all
regulators (excluding auto-regulation), and inferred regulators were identified using 5%
FDR to correct for the number of TFs tested for each target. A “joint” network was also
constructed using the same approach but applied on concatenated expression data form both
cell types (after removing mean gene expression from each cell type). Networks were
constructed on genotype-PC corrected data.
We used the joint network constructed from T4 and GN data to compare the co-expression-
based links derived here with those derived from the ImmGen data (using the Ontogenet
algorithm (7)). We decided to use the joint network as we observed a high degree of overlap
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between networks constructed individually from each cell type (see Results), and in order to
identify persistent, and thus more likely true positive, relationships. Regulatory interactions
and modules defined by Ontogenet were downloaded from the ImmGen web server
(www.immgen.org). Note that in (7) two types of modules were defined: initially 81 larger
“coarse-grained modules” were defined, and subsequently some of these modules were
refined into smaller modules with more coherent expression, resulting in 334 “fine
modules”. Coarse modules were constructed to capture the mechanisms that co-regulate a
larger set of genes in one cell-lineage, whereas fine modules were constructed to capture
distinct regulatory mechanism controlling only a smaller subset of these genes in the sub-
lineage(s). Only “fine modules” and their “top regulators”, representing more functionally
specific gene groups and links, were used in the present analyses. Based on this data, a list
of 4,083 testable links, connecting the top regulators to all genes in their assigned module
was generated. First, the replication rate for this list in the current study was computed by
assigning a p-value to each link in this study based on the co-expression of the
corresponding regulator-target pair, and then assessing the proportion of true-positive p-
values using Storey's π1 (27). To correct for the overall inflation of p-values between all
pairs of genes, as is often observed in co-expression data, we used the distribution of p-
values for co-expression of all gene-gene pairs as the null distribution to assign a p-value to
each of the 4,083 links. Second, the links identified in this study were tested for consistency
with those identified by the Ontogenet algorithm on the ImmGen data using a hypergeomtric
test---this test identified regulators whose inferred targets were also co-regulated (i.e.,
assigned to the same module) according to Ontogenet. Third, we computed the proportion of
links identified here that were also reported by Ontogenet, and used the hypergeometric test
to compute a p-value for the overlap.
Gene expression, genotype, and eQTL discovery in human
Genotype and gene expression for T4 and neutrophils were obtained from the ImmVar
study. As done for the mouse data, cis-eQTLs were defined using a 1Mb window centered
on the TSS. Gene expression data was corrected for three genotype PCs and 30 expression
PCs (to increase statistical power by removing variability due to environmental or non-local
genetic factors). The number of removed expression PCs was set by evaluating the
improvement in number of cis-eQTLs that were detected based on data from one
(“training”) chromosome (chromosome 18). In particular, to select the number of PCs that
are removed, the number of cis-eQTL discoveries in raw data was compared to PC-corrected
data where we varied the number of removed PCs from one to 50. In order to avoid
overfitting, we optimized the number of removed PCs based on cis-eQTL discovery on just
one chromosome (and not the whole dataset). As previously observed (28), the improvement
in cis-eQTL discovery greatly increased with removal of PCs, and there was a stable
plateauing effect when we removed 20-40 PCs (see for example (21)). As described for the
mouse data above, in the joint eQTL analysis, gene expression data from both cell types
were combined and a gene-level p-value was computed for each gene using permutation
analysis (1000 permutations per gene). Here, the Spearman rank correlation was used as the
test statistic.
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Constructing regulatory networks for human/mouse comparison
Stepwise regression was used to construct a regulatory network for T4 data. For this
analysis, we used the set of genes expressed in both human and mouse (in T4s) and were
considered to have non-negligible TV scores for T4 data in mouse (as defined by Figure
S1A), which resulted in a set of 3,407, of which 183 are TFs. For constructing the network,
human data was corrected for batch, population structure (three genotype PCs), gender, and
age whereas mouse data was corrected for two genotype PCs (mouse data was done in one
batch, and the mice had identical gender and age). Significant links were identified at 5%
FDR.
The replication rate of links identified in one species onto the other was computed using the
π1 statistic to quantify the proportion of true-positives among the co-expression p-values for
the relevant links (links being replicated). As above, co-expression p-values were adjusted
using the distribution of all co-expression p-values as the null.
The stepwise regression approach above identifies regulatory links in a target-centric
manner, identifying “top” regulators for each target. In addition, in a TF-centric manner, top
targets for each TF were identified based on the ranking of their co-expression value
(Pearson correlation coefficient) with the given TF. In particular, two analyses were
conducted. First, for each TF in mouse (human), top ten targets were defined based on co-
expression values, and the overlap of these targets were assessed in the top N=[10, 20, 30,
50] targets for the same TF in human (mouse). The significant of the overlaps were
determined using the hypergeometric test, and corrected for the number of TFs tested.
Second, the evidence for conservation of the top N=[10, 20, 30, 50] targets of each TF in
mouse (human) was assessed in human by using the Wilcoxon rank sum test to compare the
distribution of the co-expression values for the top N targets compared to the distribution of
co-expression values between that TF and all genes.
Results
The mice tested here included 35 classic laboratory inbred strains (M.m.domesticus) that
represent all the major branches of the inbred tree (1) and four “wild-derived” strains
(CAST/EiJ, PWD/PhJ, JF1/Ms and MSM/Ms, which are representative of the
M.m.castaenus, M.m.musculus, M.m.molossinus species, respectively). Gene expression data
for bone marrow granulocytes (GN) and CD4+ T splenocytes (T4) were quantified using
Affymetrix ST1.0 microarrays (Methods). Matching genotype data were obtained from the
Mouse HapMap Genotype Imputation Resource (29), and included 132,285 genotyped SNPs
(Methods). As we did not attempt here to identify causal variants, because of the limitations
imposed by the relatively large size of LD blocks in inbred mice, the analyses only used
genotyped SNPs for computational efficiency. All expression datacan be browsed or
accessed on the ImmGen website (www.immgen.org).
Extent and distribution of expression variation across strains
We first investigated the nature and extent of the transcript variability across the inbred
strain panel. Overall we observed some variability in expression levels for the majority of
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genes (58% of tested genes, or 8,544 genes in T4—or 39% of genes—, and 10,006 genes in
GN—46% of genes— at 5% FDR; Figure S1A). Of these, 2,508 genes in T4, and 3,711
genes in GN, had a greater than two-fold difference between the highest two and lowest two
expressing strains. Some of the most variable genes correspond to retroviral elements (Mela,
EG665955), and some to loci with known copy number variation (e.g. Cd244, Trim12, Glo1
(30)). A “true variability” (TV) score was computed for each gene (and per cell type) to
identify transcripts whose variance across the strains could be attributed to meaningful
differences, by factoring out technical factors and unwanted variability(Figure 1A; Figure
S1A). In practice we computed a TV score for each gene by contrasting a measure of within-
strain variability (computed from biological replicates) to between-strain variability
(Methods). We validated the reproducibility of these TV scores by (a) comparing them to
TV quantified from a previous gene expression dataset from macrophages for the Hybrid
Mouse Diversity Panel, which included 22 of the strains tested here(11), and (b) assessing
the correspondence with reported variability in DNA as ehypersensivity sites in eight inbred
strains (31). Reassuringly, we found a significant correlation between the TV scores in GN
and T4 with that computed from macrophage data (Spearman rho=0.26 for GN and rho=0.2
for T4, p-value<10-100) (Figure S1B). We also observed significantly higher TV scores for
genes previously identified to have variable DNase sites nearby, compared to the
background TV scores (p-value<10-3; Figure S1C).
The distribution of expression across the strains for variable genes covered a wide range,
with varying patterns (Fig. 1B,C). In most cases, a continuous spectrum was observed,
hinting at a complex genetic determinism (Figure 1C, top row). In others, bimodal patterns
were observed, which we quantified by assessing the fit of a Gaussian mixture model to
expression pattern of each gene (433 and 567 such bimodal genes for T4 and GN
expression, respectively, were identified at a Bonferroni-corrected p-value<0.05; Figures
1C; Methods). We also searched for instances of complete loss of function by using a
combination of the bimodality test and expression below the 0.05 probability of expression
in at least two strains(Methods). Overall, we identified 67 and 53complete loss-of-function
loci in T4 and GN, respectively, of which 10 lost expression in both cells (Figure 1C, middle
row; a complete list of loss-of-function loci is available from www.immgen.org). An
example gene displaying such an on/off pattern was Raet1b, which encodes a natural killer
cell lectin-like receptor ligand; it was silent in five of the strains but highly expressed in all
others. This pattern was consistent for T4 and GN, likely reflecting the variation in
composition of the Rae1α–ε family, and more generally the multiplicity of targets of
NKG2D (32). There were also several instances of “conditional loss-of-function”, loci
whose expression was sometimes absent in one cell type but present in all strains in the
other cell type (Figure 1C, bottom row); for example, Rab23 transcripts were absent in GNs
for some of strains, but present in all T4s. Several of these strains can thus serve as “natural
knockouts” or “natural knockdowns”, either directly or by backcrossing the segments
involved.
We assessed the impact of genetic variation on gene expression at a global level by
comparing the relationships between the strains inferred from gene expression data with
known genealogies and with genotype-derived relationships (Figure 2A). Simple
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examination of the parallel correlation maps of Figure 2A showed a significant
correspondence between strain relationships as derived from the gene expression data and
strain genotypes (1,33). Differences are sharper on the genotype than on the expression
matrix, most trivially because the former inherently focuses on differences (SNPs) rather
than on transcripts that are largely shared, and/or because most SNPs have no transcriptional
consequence. As expected, the wild-derived strains (CAST/EiJ, PWD/PhJ, JF1/Ms,
MSM/Ms) were more similar to each other than the classical inbred strains;the CAST/Ei
strain, derived from M. m. castaneus species, was the most distant outlier, while the two M.
m. molossinus derived strains (JF1/Ms and MSM/Ms) were more closely related to each
other. Other relationships expected from strain histories (34) include the “C57 black” group
of strains, the high pairwise similarity between CBA and C3H, or between NOD and NOR,
both of which derive from the same stock through selection for susceptibility or resistance to
diabetes (35).
For a better handle on the number and identity of differentially-expressed transcripts that
underlie these relationships, we created a genotype-based dendrogram depicting the
relationship between the strains, and identified differentially expressed genes that
characterized each group (Figure 2B). The wild-derived group was associated with 2,092
differentially expressed genes (5% FDR, of which 204 differ by a fold-change>2). These
“wild-specific” genes have a range of functionalities, as evidenced by the absence of
enrichment for any particular functional category based on GO analysis. Manual exploration
of the top associations identified several suggestive differences: the marked under-
expression of some toll-like-receptors (Tlr1 and Tlr7) in T4 cells from wild-derived strains;
several members of the NK family (Klrd1, Klrb1f) or of the interferon-response pathway
(Ifitm1, Ifitm2) were uniquely expressed in wild-derived T4;transcriptsencoding cell-surface
molecules whose distribution is normally restricted to myeloid cells (Atp1a3, CD163, and
Anxa3) but were present in T4 from wild-derived strains.
We also noted an intriguing differential expression of Eps8l1 in the C57 black group.
Mutations in Eps8 family members lead to diverse auditory phenotypes, and the C57 strains
are known to develop age-related hearing loss(36). At its inception, this project aimed to
find, in the genetic and gene expression data, correlates to the phenotypic traits of these
mouse strains, as assembled in the MPD database. Unfortunately, a systematic test for
association between gene expression levels and an extensive set of behavioral and
physiological traits (∼1500 traits from the Mouse Phenome Database) (37) did not yield
significant findings, when corrected for random association. Reasons for this may include
the limited number of strains for which complete phenotypes were available, buffering of
gene expression by regulatory networks, or that the two cell types examined here are not
relevant to the traits currently in the Phenome database.
Identifying cis-eQTLs for Neutrophils and CD4+ T cells
By correlating local genotype and expression data for the mice, we next identified specific
cis genetic variants that impact gene expression levels in T4 and/or GN (our study did not
have the statistical power to detect trans-eQTLs). To eliminate broad population-based
trends that can result in the inflation of association p-values(29), we removed the effect of
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the top two Principal Components (PC) of the genotype, which represent population
structure, from the gene expression data using linear regression. We chose two principal
components by assessing the inflation factor\lambda (24) (see Methods). We performed a
cis-eQTL analysis with the residuals of this fit, defining cis SNPs as mapping in a 1Mb
window from the transcription start site. To increase our power to detect eQTLs that are
shared by the two cell types while also detecting cell-specific eQTLs, we performed two
analyses: (1) in a “joint” analysis, we combined data from the two cell types, and evaluated
the significance of each SNP-to-gene association using permutation analysis; (2) in a “cell-
specific” analysis, we explicitly tested the significance of a cell-specific SNP effect
(Methods). In both cases, using permutation analysis, we obtained a gene-level p-value that
took into account the number of tested cis variants(25,26,38), and defined significant cis-
eQTLs at 5% FDR based on these gene-level p-values.
Using the joint analysis, we identified 1,047 genes with cis-eQTLs (Figure 3A, listed in
TableS1 and available for browsing on the ImmGen server). The joint analysis increased our
discovery power: we identified 262 eQTLs that were not detected in separate analyses of
GN and T4 data (774 and 958 eQTLs in separate analysis of T4 and GN, respectively). We
observed a significant correlation between cis-eQTL association strengths and TV
(Spearman rho=0.29, p-value<10-100).
Previous studies have identified cis-eQTLs for inbred mouse in various tissues including
liver (10,12-14), and immunocytes(10,11). We compared our set of cis-eQTLs with those
identified in macrophages(11), which was the most relevant and comparably sized. Orozsco
et al. identified 1,937 genes (corresponding to 4,897 SNP-gene pairs) with cis-eQTLs
controlling transcripts in primary macrophages that were testable in this study. To robustly
compare results, we used Storey's π1 statistic(27), and observed a replication rate of 55% (p-
value<0.001 under permutation testing). This estimate of overlap is similar to those
previously reported in the literature for studies involving different cell types or
conditions(28,39-41).
To identify cell-specific cis-eQTLs, which should denote genetic impact on cell-specific
regulatory pathways, we considered 9,698 genes that are expressed in both cell types. We
identified 234 significant cell-specific cis-eQTL, which indicates that ∼30% of discovered
cis-eQTLs are cell-specific (Figure 3B)—an estimate consistent with recent reports of
tissue- and cell-type specificity of eQTLs in human studies(40,41). For many genes with a
cell specific eQTLs signal, we found major differences between effect sizes for the
associated SNP in the two cell types (Figure 3C). This analysis also identified 17 eQTL
where expression values correlate in an opposite manner in the two cell types. For ten of the
17 genes, the same top SNP was identified from both GN and T4 data. One of the strongest
eQTL with opposite directionality of effect was observed for Pot1a (Figure 3D). The
proportion of directional cis-eQTL discovered here is similar to those previously detected
using primary immunocytes in human(21,42). This divergence may reflect the fact that a
factor recruited to the same motif acts in an opposite manner in the two cells, but it is also
possible that the SNP identified is in linkage disequilibrium with two different causal SNPs,
each active in one cell type only.
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Identifying regulatory links by co-expression analysis
Gene expression datasets that carry small “perturbations” such as those resulting from
genetic variation can be fruitfully exploited to reverse-engineer the structure of genetic
regulatory networks (43-45), with the caveat that relationships based solely on baseline co-
expression cannot resolve causal from merely correlative associations. We constructed
regulatory networks where we inferred interactions (links) between a set of 164 transcription
factors (TFs) and 3,675 candidate downstream targets using stepwise regression —this
analysis included only genes that were expressed in both cell types and had a non-negligible
TV score (as per Figure S1A). As above, to avoid artifacts from broad population structure,
we used the genotype PC-corrected data. We identified 3,462 and 3,321 significant (5%
FDR) links in T4 data and GN data, respectively, and 4,927 links in a joint network
constructed using both T4 and GN data. For these networks, few regulatory hubs correlated
with expression levels of a large number of targets (>100) and most TFs were linked to 15 or
less targets (Figure 4A,B). The major hubs mostly include chromatin modifiers and generic
transcriptional activators such as Smarcd1 and Smarce1 (SWI/SNF related chromatin
regulators), Asf1b (a histone chaperone), Phf21a (a histone deacetylase), and the histone de-
ubiquitinase Mysm1 (Figure 4B).
We evaluated the overlap between GN and T4 inferred regulatory links using Storey's π1
statistic(27). Considering only the interactions passing the statistical significance threshold
in the discovery sample (5% FDR), we estimated replication rates of π1=53% and 49%, for
T4 links in GN and vice versa, respectively, indicating that a large fraction of these
associations are shared among the two cell types. Conversely, by directly testing the
significance of a cell-type-specific effect (Methods), we estimated that 17% of total
interactions are truly cell specific (at 5% FDR). With the interaction test, Lmo2 was one of
the most differential regulatory hubs, with 51 inferred links in GN, but only four potential
target genes in T4, which likely denotes a very specific role in GN (its targets in GN do not
correspond to a distinct functional category in GO analysis).
For an independent validation of co-expression relationships identifiable from this data, we
compared a joint set of links identified from analysis of both cell types (“joint network”;
Methods) with a previous network constructed from the ImmGen compendium using the
Ontogenet algorithm. Ontogenet exploits variation in expression through differentiation
cascades to identify regulatory relationships(7). We hypothesized that true TF-target pairs
identified by Ontogenet would also show evidence of co-expression when natural genetic
variation was the network perturbant. First, we evaluated the strength of co-expression
between pairs of TF-targets previously identified by Ontogenet, and, using the π1 statistic on
adjusted p-values for co-expression correlation coefficients(Methods), we found that 27% of
these links show evidence of co-expression here. Conversely, we checked whether the
targets of each TF are also more likely to belong to the same Ontogenet module by testing
for significantly enriched Ontogenet modules among the predicted targets of each TF using
the hypergeometric test. For 11 of the 127 TFs with at least 10 inferred targets, the targets
were significantly enriched in an Ontogenet (fine) module at 5% FDR (Table S2). For
example, Srebf2, which encodes asterol regulatory TF, was associated with 33 genes here, 9
of which were part of the same module and predicted by Ontogenet to be regulated by
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Srebf2(p-value<10-15; Figure 4C). Another well-known set of replicated links was between
Irf9 and six of its known targets within the interferon response signature (p-value<10-8;
Figure 4C). Although less robust to differences in inference method and sample sizes, we
also directly evaluated the overlap between the inferred regulatory links here and that of
Ontogenet, where we observed a modest (4%) but significant overlap (hypergeometricp-
value<10-10).
Co-expression relationships that underlie the regulatory links here are not conclusive of
directionality. To disentangle causal from simply correlative associations in the present
network, we examined the propagated influence of cis variants associated with the inferred
TFs (46). In practice, we asked whether a cis-eQTL SNP for a TF was also correlated with
the expression levels of the TF's inferred targets. Within the set of links identified in the
joint network (4,927 links) 230 links were testable as they were incident to one of the 15
TFs for which a cis-eQTL had been identified above; 50 links(22%) were “causally”
supported, in that the genotype at the cis-eQTL was significantly associated with the
expression of the TF's targets at 5% FDR.
Comparison of variation in gene expression in human and mouse
Comparative studies of gene expression patterns across species have mainly focused on
comparing similarities and differences in expression across tissues, cell types, or responses
to triggers. In these studies, conserved cell-type specificity or response to similar triggers
across species is taken to indicate conserved functionality(19,47-52). The impact of genetic
variation in each species is averaged, smoothed or factored out in such analyses. Instead, we
sought to exploit the diversity of genetic background across inbred mice and across the
human population sampled in the ImmVar study (which includes 360 healthy individuals
from Asian, Africa, and European backgrounds with available expression data for CD4 and
CD14 cells - the derivation and analysis of ImmVar datasets are detailed elsewhere (21)).
ImmVar was designed to match the present analysis in several respects (parallel profiling of
CD4+ T in both human and mouse). We took advantage of these congruent datasets to
explore the similarities and differences in expression variability, impact of cis regulatory
variation, and inferred regulatory interactions in mouse and human. For this analysis, we
considered 14,130 genes with one-to-one human/mouse orthology (MGI HMD_Human5
set), and restricted the analysis to 5964 genes expressed in T4 (we only analyzed the T4
data, because of the exact correspondence of this cell type in our data from the two species).
First, we applied the same TV metric of variation discussed above to compare the variability
in genes' expression in human and mouse. The TV scores were calculated for human genes
by using replicate samples prepared from the same donor (collected at intervals ranging
from 3 to 25 weeks) after accounting for batch, age, and gender (using linear regression).
The TV metric allowed us to eliminate gene-wise technical variability and only capture
biological variability (responding to environmental and/or genetic cues). Human versus
mouse comparison of the TV scores showed interesting patterns (Figure 5A-C); some genes
were variable in one species or the other, but in general there was a correlation between TV
in mouse and human (Spearman rho=0.16, p-value<10-10). We categorized genes into five
equally-sized bins in each species based on TV scores and found significant predictability of
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TV scores in the second species based on the assigned bin in the first species (Figure 5C;
Wilcoxon rank sum test p-values 10-4 to 10-8 for bins created in mouse and human,
respectively): for example 26% of the genes in the top bin (most variable) in one species are
also categorized in the top bin the other species.
The variability captured by the TV metric encompasses environmental and other factors
beyond the impact of genetic variation. To compare the extent of genetically determined
variation in gene expression in both species, we evaluated the overlap of cis-eQTLs in
human and mouse. Using the same methodology as above, we identified 2,285 cis-eQTL
genes in the human ImmVar datasets among the set of 7,098 expressed genes in both species
(either cell type)(eQTLs identified using the joint analysis; Methods). Of the 674 genes
associated with an eQTL discovered in mice for this set of expressed genes, 275 were also
associated with an eQTL based on human data (hypergeometirc p-value<10-6), implying that
genes which show a significant impact of local genetic variation tend to overlap in mice and
humans, even though the variants themselves are certainly unrelated.
Next we compared gene regulatory networks constructed from the T4 dataset for both
human and mouse. The motivation was to analyze the evolutionary conservation of these
regulatory links, and from a practical standpoint to validate the inferences by confirmation
in another species. For each species, we first constructed a network using stepwise
regression as above (Methods). At a global level, we observed a correlation between TFs'
out-degree (the number of targets connected to each TF; Figure 5D), with 38% of the top
20% hubs in one species shared with the second species (p-values <0.01). Per above,
chromatin modifiers tend to be strong regulatory hubs in both species. We used the π1
statistic to estimate the fraction of TF-to-target links identified in one species that are
replicated in the second species. A 47% replication rate was observed for mouse links in the
human T4 dataset, and a 19% replication rate for human links in the mouse dataset
(permutation analysis p-value<0.001) (Figure S2A,B). Finally, in a regulator-centric
analysis, we also assessed the correspondence between top co-expressed links for each TF in
the two species. To do so, we assessed the overlap and the distribution of co-expression
values (correlation coefficients) for the top N=[10,20,30, 50] targets of each TF in the
second species (Methods). Of the 189 TFs that were analyzed, we identified 17 TFs whose
top 10 targets were highly conserved (hypergeometic test p-value<10-6; Figure 5E), and the
top targets of an additional set of 42 TFs showed significant evidence of high co-expression
values in the second species (using the Wilcoxon rank sum test; Figure S2C,D). Among
these highly conserved co-expression links, we identified well-known relationships,
including co-expression between Irf9 and interferon response genes Dh×58, Ifi35, Irf1, Pml,
Trafd1, Stat2 and strong co-expression between Jun and Fos and known early response
genes (Ier2, Gadd45b). We did not attempt to interpret the divergent regulatory links within
these datasets: these are not conclusive of true differences, since multiple confounding
factors can underlie such differences (different environmental influences, much smaller
sample size for the mouse data, imperfect mapping of human to mouse probes). Overall,
these comparisons show that many of the regulatory connections that can be inferred from
the inter-individual variation in expression profiles are conserved between these two
mammalian species.
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Discussion
Our motivation, in the context of the ImmGen and MDP programs, was three-fold: to serve
as a reference of genomic and genetic information relevant to the immune function in
mouse; to provide additional material for the dissection of genetic regulatory networks; to
provide a documented basis for comparison of the mouse and human immune systems.
In terms of resource, the present data provide useful information at several levels, and are all
available interactively from the ImmGen and MDP web browsers
(www.immgen.org,phenome.jax.org). We detected a number of genes with greater than a
two-fold change in expression across the strains (the empirical rule-of-thumb for functional
significance). It will be interesting to see how these traits segregate in settings such as the
Collaborative Cross strains, where the chromosomal segments can be traced in the
recombinant chromosomes, allowing refinement of the genetic control and/or discovery of
epistatic modifiers. Variation followed both bimodal and continuous expression patterns
across mouse strains, including a few loci with complete loss of expression in some of the
mouse strains. As such, these can serve as are source of “natural knockdowns” or “natural
knockouts” (some affecting both cell types, others cell-specific). The 1,222 cis-eQTLs
detected in the two immunological cell types are also available through the dedicated
ImmGen interface. However, the relatively large size of the LD blocks in these inbred
mouse strains, relative to outbred humans or mice(22), make it impossible to pinpoint with
precision the causal variant, and the SNPs listed should only be considered as likely proxies
of the truly relevant variant. Never the less, the patterns of variation and the eQTLs
described here, and their conservation across species, may help to interpret differences in
susceptibility to infection or autoimmune diseases, in a manner than translates to genetic in
risk human populations.
The patterns of inter-strain variability followed, as expected, the patterns of genetic distance
and genealogical history between the strains. Wild-derived strains were predictably more
distant from the classic inbred lines. Some of this genetic distance may be directly related to
selective events during mouse domestication or to the input from non-domesticus
subspecies. We previously reported that a variant at the Il1b locus, which leads to a 5- to 10-
fold greater Interleukin-1 response to stimulation through innate receptor pathways, is
frequent in wild-derived strains but quite rare among classical inbred strains (53), and some
of the expression variations uncovered here may be of the same nature (e.g. Tlr1 and Tlr7,
although in this instance it is the wild-derived strains that show low or absent expression in
T4). Some genes whose expression is normally confined to myeloid cells were expressed in
CD4+ T cells of the wild-derived strains. Some of these conditionally expressed genes are
surprising, such as the expression of CD163, a scavenger receptor on macrophages whose
function in CD4+ T cells is not immediately obvious. We might speculate that this reflects a
mode of innate sensing by CD4+ T cells that was lost during domestication (interestingly,
however, human T cells do not express these monocyte genes).
The distribution of cis-acting genetic variation was significantly correlated with the variation
in expression for the most variable genes, although many of the genes with a high TV score
did not show an active cis-eQTL. Recent literature indicates a larger impact for local
Mostafavi et al. Page 14
J Immunol. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
sequence variation, which may have been detectable with larger sample sizes(28,54),
perhaps attainable with a larger study of outbred or Collaborative Cross mice. We note that
the number of cis-eQTLs detected here is more than what would be expected from an
equally sized human dataset (28) where the effect of environment cannot be as effectively
controlled.
The co-expression-based network estimated here extended the analysis of the regulatory
networks of immunocytes initiated in ImmGen(7), and we observed a comforting degree of
overlap between the two analyses. Although co-expression cannot formally identify causal
directionality in a correlated pair (i.e. who controls whom), the selection of transcriptional
regulators provides a functional prior for directionality. Indeed, when we searched for causal
chains of associations, by correlating a cis variant impacting the expression of a TF with the
TF's downstream effects on its inferred targets, a significant portion (22%) of the testable
links turned out to be causally driven. Interestingly, connections identified from inter-strain
variation more frequently involved generic regulators such as chromatin modifiers, which
showed up here as major hubs, than classic sequence-specific DNA-binding TFs and lineage
determination factors (which were predictably more prevalent in the Ontogenet analysis).
This difference is in line with the paucity of cis-eQTLs for classic transcription factors
regulators involved in differentiation or lineage determination, as previously shown in
human cells (28,55). One might speculate that a degree of “noise” in transcript level
resulting from variations in redundant and pleiotropic factors is better tolerated (or even
favored) than variation in more specific factors that form the blueprint of cell differentiation
and lineage determination. This dominance of broad transcriptional regulators as major co-
expression hubs was strikingly reproduced in the human datasets.
Finally, we observed sharing of the patterns of expression variability between human and
mouse. Both genetic and non-genetic factors can result in expression variability, and we also
observed significantly non-random overlaps in genes that are associated with cis-eQTLs in
both species. From an evolutionary standpoint, this “conservation of variability” can be
explained by species-shared strength of selection pressure on gene expression levels (56):
variation in more redundant and/or less essential genes is better tolerated, and these
characteristics would tend to be conserved. It is also possible that some of this species-
shared variability is in genes whose intra-species variation is favorable. The extraordinary
diversification of coding sequence in MHC genes favors heterozygosity in individuals and
diversity at the level of the species to best meet variable pathogen challenges (57). Similarly,
it may be advantageous to diversify the levels of expression, and hence of response
potential, in pathways of the immune system. Genes controlling activating and inhibitory
NK receptors would plausibly fall in that category. From a mechanistic standpoint, one
might also imagine different scenarios for the roots of this reproducible variability: some
regions of the genome may be inherently noisier, a characteristic preserved during the
evolutionary shuffling of syntenic chromosomal regions; regulatory feedback loops that
control individual genes or sets of genes may be more or less robust; miRNAs or other non-
coding RNAs might make for a variable degree of control. Any of these mechanisms may
have been, to an extent, preserved through 200 million years of evolution, to conserve
immunologically relevant variation.
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Figure 1. The extent and patterns of gene expression variation between inbred mice
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Figure 2. Expression-based and genotype-based strain similarities
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Figure 3. GN and T4 joint-discovered and cell-specific cis-eQTLs
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Figure 4. Analysis of gene co-expression in mouse
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Figure 5. Sharing of variability and co-expression in mice and humans
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